Title:
PYRAZOLONE AND PYRIMIDINE COMPOUND, AND PREPARATION METHOD AND USE THEREFOR
Document Type and Number:
WIPO Patent Application WO/2020/259724
Kind Code:
A3
Abstract:
Disclosed in the present invention are a pyrazolone and pyrimidine compound, and a preparation method and a use therefor. Provided in the present invention is a pyrazolone and pyrimidine compound as in formula (I), said compound having better inhibitory activity towards WEE1 kinase.
More Like This:
| WO/2023/125681 | HETEROCYCLIC COMPOUNDS |
| JP4845730 | PPAR active compound |
| JP2634386 | SYNTHETIC INTERMEDIATE FOR 1-CARBA(DETHIA)CEPHALOSPORIN ANTIBIOTIC |
Inventors:
WANG QIAN (CN)
HUO GUOYONG (CN)
XIA GUANGXIN (CN)
LOU JIANGSONG (CN)
SHU SIJIE (CN)
GE HUI (CN)
ZHANG LIN (CN)
SHI CHEN (CN)
ZHANG ZHIHUI (CN)
MAO YU (CN)
ZHANG BINGBIN (CN)
YU JIANXIN (CN)
LIU YANJUN (CN)
HUO GUOYONG (CN)
XIA GUANGXIN (CN)
LOU JIANGSONG (CN)
SHU SIJIE (CN)
GE HUI (CN)
ZHANG LIN (CN)
SHI CHEN (CN)
ZHANG ZHIHUI (CN)
MAO YU (CN)
ZHANG BINGBIN (CN)
YU JIANXIN (CN)
LIU YANJUN (CN)
Application Number:
PCT/CN2020/112034
Publication Date:
February 18, 2021
Filing Date:
August 28, 2020
Export Citation:
Assignee:
SHANGHAI PHARMACEUTICALS HOLDING CO LTD (CN)
International Classes:
C07D487/04; A61K31/519; A61P35/00; C07D471/04; C07D519/00
Domestic Patent References:
| WO2019173082A1 | 2019-09-12 | |||
| WO2018133829A1 | 2018-07-26 | |||
| WO2019074979A1 | 2019-04-18 | |||
| WO2019028008A1 | 2019-02-07 | |||
| WO2017075629A2 | 2017-05-04 |
Foreign References:
| CN109422754A | 2019-03-05 | |||
| CN109810111A | 2019-05-28 |
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF: